The VA opened enrollment in CRAVE, a placebo-controlled trial of semaglutide for alcohol use disorder in more than 600 veterans at 18 medical centers.
VA Launches a Randomized Trial Testing Whether Semaglutide Can Reduce Drinking in Veterans
by | Aug 4, 2026 | Uncategorized | 0 comments
Recent Comments